Polyethylenimine Linear (PEI, MW 40,000): Benchmark DNA Transfection Reagent for In Vitro Studies

Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer widely adopted for efficient DNA transfection in mammalian cells, achieving 60–80% efficiency in serum-containing media (Li et al., 2025, DOI). It condenses DNA via electrostatic interactions, enhancing endocytosis-mediated uptake. The APExBIO K1029 kit supports scalable workflows, from 96-well plates to 100L bioreactors (product page). PEI-mediated transfection is proven compatible with key cell lines including HEK-293, CHO-K1, and HeLa. Adoption of standardized PEI protocols underpins reliable recombinant protein production and functional genomics investigations.

Biological Rationale

Polyethylenimine Linear (PEI, MW 40,000) is a synthetic, water-soluble, linear polyamine. It is positively charged at physiological pH, allowing efficient binding to negatively charged nucleic acids (DNA, RNA). This property is critical for condensing DNA into nanoparticles suitable for cellular uptake (APExBIO). The rationale for PEI use is based on mimicking natural polycationic protein–DNA interactions, facilitating delivery of genetic material into eukaryotic cells by overcoming the repulsion between DNA and the anionic cell membrane. PEI’s compatibility with serum-containing media enables its use in standard cell culture conditions, reducing the need for medium changes and minimizing cellular stress during transfection (see prior review: This article updates with new neuroinflammation modeling data).

Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

PEI Linear (MW 40,000) forms electrostatic complexes with DNA, condensing it into small, positively charged particles. These complexes interact with cell-surface proteoglycans and other anionic residues, triggering uptake by clathrin-mediated endocytosis (Li et al., 2025). Following internalization, PEI’s high buffering capacity—known as the 'proton sponge effect'—leads to osmotic swelling and endosomal membrane disruption, facilitating DNA release into the cytoplasm. The high molecular weight and linear structure of PEI MW 40,000 provide optimal balance between DNA condensation, cellular uptake, and cytoplasmic release, outperforming lower molecular weight or branched PEI variants in many experimental settings (cf. application strategies: Here, advanced mechanistic insights are linked to disease modeling).

Evidence & Benchmarks

• PEI Linear (MW 40,000) achieves 60–80% transfection efficiency in HEK-293, CHO-K1, and HeLa cells under standard conditions (37°C, serum-containing DMEM, 5–10 µg DNA/10⁶ cells, 2–6 hours exposure) (Li et al., 2025).
• Transfection remains effective in the presence of 10% fetal bovine serum (FBS), minimizing cytotoxicity and supporting cell viability (>85%) (APExBIO).
• PEI-mediated delivery supports transient recombinant protein yields up to 50–200 mg/L in suspension-adapted HEK293 cultures in 1–10 L bioreactors (see translational perspective: This article details clinical modeling not covered here).
• PEI Linear (MW 40,000) enables robust gene perturbation in neuroinflammation models, such as H3K18 lactylation–NOD2–mediated astrocyte pyroptosis (Li et al., 2025).
• Repeat freeze–thaw cycles reduce PEI activity; storage at –20°C preserves reagent integrity for >12 months (APExBIO).

Applications, Limits & Misconceptions

PEI Linear (MW 40,000) is widely applied for DNA transfection in in vitro studies, transient gene expression, and recombinant protein production. It is routinely used for high-throughput screening, CRISPR/Cas9 delivery, and epigenetic research. The reagent is compatible with multiple cell lines, including HEK-293, HEK293T, CHO-K1, HepG2, and HeLa. In neurobiology, PEI-mediated transfection underpins studies of gene regulation in astrocytes and inflammation, as demonstrated in models of bilirubin-induced pyroptosis (Li et al., 2025).

For additional workflow strategies, see this roadmap article, which integrates recent advances in epigenetic modeling—expanding on the current focus by discussing clinical translation.

Common Pitfalls or Misconceptions

• PEI Linear (MW 40,000) is not recommended for in vivo gene delivery due to rapid clearance and potential toxicity.
• Branched PEI or lower molecular weight PEI variants may not achieve comparable transfection efficiency or cytocompatibility.
• Overloading with DNA or PEI can increase cytotoxicity without improving transfection rates.
• Serum-free conditions are not required; however, use in primary cells may yield variable results and require optimization.
• Repeated freeze–thaw cycles degrade reagent performance; aliquoting is recommended for frequent use.

Workflow Integration & Parameters

The APExBIO Polyethylenimine Linear (PEI, MW 40,000) K1029 kit is supplied at 2.5 mg/mL in 4 mL or 8 mL vials. For transfection, DNA and PEI are typically diluted separately in non-buffered saline (e.g., 150 mM NaCl), mixed at an N/P ratio of 10–15 (amine:phosphate), and incubated for 15–20 minutes at room temperature to allow complex formation. The complexes are added directly to cells cultured in serum-containing media. Optimal DNA:PEI ratios and exposure times should be experimentally determined for each cell line and application.

For experimental design in neuroinflammatory disease modeling, PEI-mediated transfection enables rapid perturbation of regulatory axes such as H3K18 lactylation–NOD2, supporting both mechanistic and translational studies (see application note: Here, novel strategies for scaling and protein expression are discussed in more detail).

Conclusion & Outlook

Polyethylenimine Linear (PEI, MW 40,000) is a benchmark DNA transfection reagent for in vitro studies, enabling high-efficiency, scalable, and serum-compatible gene delivery. Its role in advancing neurobiology and recombinant protein production is evidenced by robust, reproducible results in diverse mammalian cell lines. Ongoing research seeks to further optimize transfection parameters and extend PEI’s utility to emerging applications in functional genomics and disease modeling. For detailed specifications and ordering, visit the APExBIO product page.